Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 7.48B | 7.00B | 7.26B | 5.98B | 4.58B | 5.74B |
Gross Profit | 2.23B | 1.99B | 1.96B | 1.35B | 1.48B | 1.49B |
EBITDA | 1.16B | 1.07B | 1.09B | 648.16M | 632.37M | 549.48M |
Net Income | 683.48M | 578.91M | 578.36M | 288.51M | 309.41M | 307.82M |
Balance Sheet | ||||||
Total Assets | 11.61B | 11.56B | 11.81B | 10.99B | 9.68B | 8.52B |
Cash, Cash Equivalents and Short-Term Investments | 2.27B | 1.67B | 1.52B | 971.51M | 771.23M | 819.50M |
Total Debt | 1.38B | 1.37B | 1.45B | 1.52B | 1.02B | 10.00M |
Total Liabilities | 3.95B | 3.74B | 4.50B | 4.20B | 3.11B | 2.19B |
Stockholders Equity | 7.66B | 7.82B | 7.31B | 6.80B | 6.57B | 6.33B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 376.50M | 684.25M | -332.69M | -1.09B | -728.03M |
Operating Cash Flow | 0.00 | 542.21M | 842.83M | 380.69M | 786.17M | 70.21M |
Investing Cash Flow | 0.00 | -245.75M | -155.18M | -611.36M | -1.77B | -89.47M |
Financing Cash Flow | 0.00 | -148.34M | -134.83M | 430.95M | 932.11M | -68.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥5.54B | 9.99 | 3.69% | 10.05% | 8.17% | ||
73 Outperform | ¥5.53B | 9.55 | 1.20% | -3.54% | 0.10% | ||
72 Outperform | ¥5.25B | 4.52 | 1.41% | 0.96% | ― | ||
67 Neutral | £2.80B | 13.41 | 4.69% | 3.43% | 2.35% | -24.51% | |
65 Neutral | ¥5.09B | 8.85 | 5.61% | -15.22% | -37.99% | ||
51 Neutral | ¥5.28B | ― | 2.07% | -2.05% | -14.68% | ||
51 Neutral | ¥5.28B | ― | 1.83% | 10.20% | -142.32% |